Pediatric TransplantArchives
Inherited metabolic diseases are a potent risk factor for cytomegalovirus infection in pediatric living donor liver transplantation
Pediatric Transplant 5 min.
Cytomegalovirus (CMV) disease is a common infection following solid organ transplantation, posing significant challenges in clinical management due to its association with both morbidity and, in some cases, mortality. Beyond its immediate effects, CMV contributes to a range of short-term and long-term...
Hemorrhagic cystitis in pediatric severe aplastic anemia undergoing haploidentical hematopoietic stem cell transplantation: incidence, risk factors and outcomes
Pediatric Transplant 4 min.
Severe aplastic anemia (SAA) is an uncommon and life-threatening disease, marked by bone marrow failure and pancytopenia [1]. Immunosuppressive therapy (IST) and matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) are the preferred recommended treatments [2]. However, IST is ineffective...
Clinical and molecular genetic characteristics of pediatric PFIC3 patients: three novel variants and prognosis for parental liver transplantation
Pediatric Transplant 5 min.
PFIC3 is a rare recessive liver disorder that falls within the category of Familial Intrahepatic Cholestasis (PFIC). PFIC is a spectrum of inherited disorders of intrahepatic cholestasis, arising from various genetic mutations. The global incidence of PFIC is estimated to be between 1 in 100,000 and...
Characterization of emergency department visits in pediatric patients within first year of liver transplantation: ten years experience in tertiary care center
Pediatric Transplant 6 min.
Liver transplant is one of the major advances in medicine and one of the most performed surgeries in transplant. In the Kingdom of Saudi Arabia, the first liver transplant was performed in 1991. However, pediatric liver transplant didn’t start until 1997, trailed by adult living donor transplant...
